Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures (Q48908276)

16 February 2018

title

Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures (English)

1 reference

16 February 2018

author

Vinícius Rafael Funck

1 reference

16 February 2018

Leandro Rodrigo Ribeiro

1 reference

16 February 2018

Juliano Ferreira

object named as

Juliano Ferreira

1 reference

16 February 2018

Gustavo Petri Guerra

object named as

Gustavo Petri Guerra

1 reference

16 February 2018

author name string

Clarissa Vasconcelos de Oliveira

1 reference

16 February 2018

Letícia Meier Pereira

1 reference

16 February 2018

Leonardo Magno Rambo

1 reference

16 February 2018

Luiz Fernando Freire Royes

1 reference

16 February 2018

Ana Flávia Furian

1 reference

16 February 2018

Maurício Schneider Oliveira

1 reference

16 February 2018

Carlos Augusto Mallmann

1 reference

16 February 2018

Carlos Fernando de Mello

1 reference

16 February 2018

Mauro Schneider Oliveira

1 reference

16 February 2018

publication date

11 September 2011

1 reference

16 February 2018

published in

Epilepsia

1 reference

16 February 2018

volume

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

2094-2104

1 reference

16 February 2018

What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

A historical perspective on the discovery of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Molecular cascades that mediate the influence of inflammation on epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Withdrawal of statin treatment abrogates stroke protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Structural mechanism for statin inhibition of HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Seizure-promoting effect of blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

The etiological role of blood-brain barrier dysfunction in seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the alpha 4 subunit of the neuronal nicotinic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Correlation between breakdown of the blood–brain barrier and disease outcome of viral encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Clinical Aspects of Niemann-Pick Type C Disease in the Adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03261.X

10.1111/J.1528-1167.2011.03261.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018